Phase I/II Study of AC0010, Mutant Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation
JOURNAL OF THORACIC ONCOLOGY(2017)
关键词
Phase I/II study,NSCLC,T790M,AC0010
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要